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Adenomatoid mesothelioma of the peritoneum (AMP) is 
a rare benign tumor originating from mesothelial cells.1 Most 
frequently, AMP occurs between 26 and 55 years of age, at 
a mean age of 41 years.1 In contrast to diffuse malignant 
mesothelioma, which has been linked to asbestos exposure, 
the etiology of AMP has not been established.2 Only a 
minority of patients have symptoms related to the tumor. 
AMP may present local recurrence, but it has no potential 
for malignant transformation.3 Although there are many case 
reports of abdominal mesotheliomas, to date, there have been 
no reports of MR imaging features of AMP. In this article, 
we present the MR imaging features of a case of AMP with 
histopathological correlation.
CASE REPORT
A 25-year-old woman presented with pelvic pain. The 
patient had had a cesarean section 3 years before her visit 
and an appendectomy about 6 months earlier than her onset. 
Routine ultrasound exam showed an expansive pelvic lesion 
suggesting an adnexal origin, most likely an ovarian neoplasm, 
and this finding was confirmed by two other ultrasound exams, 
each one performed at a different facility. A pelvic-abdominal 
MR exam was requested for lesion characterization. 
Laboratory tests were within normal values, except for CA125 
of 37.9 µ/ml (normal range 0.0 to 35.0 µ/ml).
Imaging Findings
Transvaginal pelvic sonography showed a retrouterine 
adnexal mass extending towards the left parauterine region 
with a complex echotexture containing a homogeneous 
solid component about 5.0 cm in size and small cystic areas 
intermingled with linear septa. The mass measured 10.8 x 
6.1 x 10.5 cm (volume of 359.7 cm3). Color Doppler imaging 
demonstrated vascularization of the solid area and of some 
septa in the cystic region, with a resistive index ranging from 
0.60 to 0.70. Ovaries were identified in neither ultrasound 
exam. There was no sign of ascites (Figure 1). 
The MR images demonstrated a large, expansive, and 
well-delimited lesion with lobulated contours; T1-weighted 
images showed homogeneous signal intensity predominately 
with a low signal, whereas T2-weighted sequences were 
heterogeneous with small high intensity foci (Figure 
2). There was a slightly heterogeneous enhancement in 
post-contrast T1-weighted images that was more evident 
peripherally (Figure 2). The lesion measured 9.2 x 7.2 x 
8.0 cm and was located close to the ovaries, which were 
dislocated anterolaterally. The contours, dimensions and 
signal intensity of the ovaries were normal. The uterus was 
normal in shape, dimensions and signal intensity, and it was 
also dislocated anteriorly. A small amount of free fluid was 
present in the peritoneal cavity surrounding the lesion. The 
upper abdominal MR evaluation showed the extension of 
the free peritoneal fluid and normal anatomy of abdominal 
organs. Computed tomography of the pelvis without 
Figure 1 - Transvaginal pelvic ultrasound images (A,B) showed a complex 
retrouterine mass with a homogeneous solid component (*, B) and cystic 
areas (arrowhead, A) intermingled with linear septa (arrow, A)265
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intravenous injection of contrast agent was performed to 
search for calcification and showed a low homogeneous 
coefficient of attenuation for the lesion, ranging from – 2 to 
+10 U.H, with no evidence of calcification (Figure 3).
Patient outcome
The patient was submitted to open abdominal surgical 
resection of the lesion, which had adherences to the rectal 
anterior wall but no invasion of the uterus or adnexa. 
Macroscopic anatomopathological examination revealed 
various irregular fragments of brownish, friable tissue 
that measured 15.0 x 12.0 x 4.0 cm and weighed 170.0 
g. Microscopic analysis revealed a well-differentiated 
mesothelial neoplasia, which is detailed in Table 1. 
Immunohistochemistry evaluation was carried out in the 
histological sections with an immuno-peroxidase reaction 
via the avidin-biotin peroxidase method, with the primary 
antibodies calretinin + CEA- and BerEp4- (Figure 4).
A  follow-up  MR  exam  revealed  an  expansive, 
predominantly cystic lesion with high protein content 
located in the posterior cul-de-sac; this lesion had shown 
a progressive increase in volume over 3 years and was 
characterized as a recurrent tumoral lesion (Figure 5). 
Figure 2 - Pelvic MR exam. Axial GRE T1-weighted (A), axial TSE 512 
T2-weighted (B), sagittal post-contrast GRE T1-weighted image and (D) 
sagittal TSE T2-weighted images. There is a large, expansive, well-delimited 
lesion with lobulated contours; the T1-weighted sequence shows homoge-
neous signal intensity predominately with a low signal, and T2-weighted 
sequences are heterogeneous with small high-intensity foci (arrow). The le-
sion dislocated the ovaries (arrowheads, B) anterolaterally and the uterus (*, 
A,C and D) anteriorly. After intravenous injection of paramagnetic contrast 
agent, there was a heterogeneous enhancement of the lesion that was more 
evident peripherally (arrowheads, C)
Figure 3 - Computed tomography with no intravenous contrast agent revealed 
that there was no calcification within the mass (arrows)
Table 1 - Histopathological findings of the reported case 
Origin Primitive
Histogenetic lineage Mesothelial
Structural differentiation Well-differentiated
Supporting tissue Loose – vascularized
Predominant cell type Medium size – Polygonal 
Cell arrangement Acinar – Tubular – Papilliform
Cytoplasm characteristics Abundant – Microvacuolized – 
Basophilic 
Nucleus characteristics Medium volume – Round – Discrete 
nucleoli – Fine chromatin – 
Homogeneous chromatin
Nucleus/cytoplasm ratio Maintained
Extracellular material produced Absent
Mitotic index Low (up to 1)
Degree of necrosis Absent
Degree of atypy Mild
Cytologic (nuclear) grade 1
Histological grade I
Capsular limits  Absent
Tumor limits Poorly defined
Vascularization Abundant
Forms of infiltration Absent
Inflammatory infiltrate Present
Predominant cells Lymphocytes – Histiocytes
Microcalcifications Present – Focal 
Desmoplasia Absent
Hemorrhage Absent
Vacuolar embolization Not visualized
Lymphatic embolization Not visualized
Perineural infiltration Not visualized
Surgical safety margins Poorly defined266
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The lesion was resected surgically, and there was no sign 
of recurrent disease on subsequent follow-up exams. The 
patient is currently asymptomatic. 
DISCUSSION
Mesotheliomas are rare tumors originating from 
mesothelial cells of serosal membranes such as the 
pleura, peritoneum,4 pericardium, and tunica vaginalis.1 
Simultaneous pleural and peritoneal involvement occurs 
in 30-45% of cases, whereas disease limited to the 
peritoneum occurs in 10 to 20% of the patients.5 Peritoneal 
mesotheliomas can be classified as benign (adenomatoid, 
fibrous),3,6 borderline (multicystic, well-differentiated 
papilliferous),1,4, 7,8 and malignant (epithelioid, sarcomatoid 
or biphasic/mixed),8 and their characteristics are described 
in Table 2.
Peritoneal adenomatoid mesothelioma (AMP) is a benign 
neoplasia9,10 of unknown etiology that primarily involves 
the genital tract of both sexes,9,10 occurring more frequently 
among males.1,3,8,11-13
We  report  here  a  case  of  a  25-year-old  woman 
diagnosed with AMP that was confined to the peritoneum. 
Among women, adenomatoid tumors are more commonly 
encountered in the myometrium (posterior wall of the 
uterus), in the fallopian tubes, in paraovarian connective 
tissue,1,10-12 and rarely in the ovaries.1,9 In our patient, the 
uterus and ovaries were free of disease, and the lesion was 
confined to the peritoneum.
Among males, in most cases the tumor is detected in the 
inferior pole of the epididymis,9,10 but it can also involve 
the ejaculatory duct, sperm cord, tunica albuginea, tunica 
vaginalis, testicular parenchyma, prostate, and rarely the 
spermatic funiculus.1,9-13
Adenomatoid tumors have also been detected in the 
omentum, mesentery, pancreas, liver, bladder, mediastinal 
lymph nodes, pleura, heart, and adrenal glands.3,9,11,13 
The cause of the apparent predominance in the genital 
tract when compared to other mesothelial locations 
has not been explained.3 Historically, adenomatoid 
tumors have always attracted interest regarding their 
histological origin, and several hypotheses have been 
proposed. Immunohistochemical studies favor mesothelial 
histogenesis.1,10 The “adenomatoid” designation was 
introduced by Golden and Ash in 19451,9,10 because of the 
arrangement of the cells in a cohesive manner, forming 
tubules and canaliculi. Four histological patterns of 
adenomatoid tumors have been identified and classified as 
adenoid, angiomatoid, solid or cystic.1,3 The histological 
pattern of the present case was classified as solid. The peak 
incidence of this tumor is between the 3rd and 5th decades 
of life, between 26 and 55 years (mean: 41 years), with an 
extremely rare occurrence in children.1,10
AMP is an uncommon tumor,3 usually asymptomatic,9 
and is incidentally discovered during radiologic exams, 
surgeries or autopsies.3,9 It is typically a single polypoid or 
nodular small lesion (2.0 cm or less)1,14 that can measure 
up to 13 cm in diameter in a few cases.1 Adenomatoid 
tumors are usually solid, not encapsulated and often contain 
small cystic lesions (0.4 to 1.5 cm).12 When present, signs 
and symptoms are abdominal pain, loss of weight, loss of 
appetite, nausea, fluid accumulation in the peritoneal space 
(ascites), and a pelvic mass.8
In the present case, the tumor was 15 cm at its widest 
diameter on pathological examination, exceeding the 
size of previously reported masses. This might explain 
why the patient was symptomatic; additionally, after 
surgical resection, symptoms disappeared for a period of 
approximately one year. After that, the lesion recurred, and 
the patient was submitted to a new surgical intervention. The 
patient has now been free of the disease for 7 years.
Usually, surgical resection is the treatment of choice for 
AMP. Accurate diagnosis and staging are important because 
of the obvious therapeutic implications.15 Although benign, 
AMP is a source of great concern due to the differential 
diagnosis of malignant entities.10
In the present case, in view of the location of the tumor 
Figure 4 - The histopathologic section shows calretinin staining for well-
differentiated mesothelial cells (*), which confirms the mesothelial origin 
of the tumor
Figure 5 - Follow-up pelvic MR exam. Axial TSE T2-weighted (A) and 
post-contrast axial GRE T1-weighted (B) images show a retrouterine, large, 
well-delimited cystic lesion with internal post-contrast-enhanced nodules 
(arrows) and partial septations (arrowhead). This lesion was surgically ex-
cised and histopathologically confirmed as to be a recidivate mesothelioma 
(u, uterus)267
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Table 2 - Features of mesothelioma-type tumors as reported in the literature
Well-differentiated 
papilliferous perito-
neal mesothelioma 2 
Multicystic peritoneal 
mesothelioma 4, 6, 7, 22-25
Fibrous peritoneal 
mesothelioma 6
Malignant peritoneal 
mesothelioma 16, 26
Peritoneal adenoma-
toid mesothelioma 
[1,3,5,10-13]
Mean patient age 30 to 50 years
(46.1 ± 13.65 years)
37 years and 10 months  40 to 70 years 26 to 55 years (average 
of 41 years old)
Sex Predominance in 
women (65.9%)
Predominance in 
women of reproduc-
tive age 
Predominance in 
men, 2 to 10 times 
more common than in 
women
Predominance in men
Risk factors No established etiology  History of abdomi-
nal surgery (53% of 
cases), endometriosis 
or inflammatory pelvic 
disease.
No etiologic associa-
tion with asbestos. 
Chronic peritoneal 
irritation and previous 
laparotomy
Exposure to asbestos 
(15 to 30 % of cases)
Exposure to beryllium, 
nuclear radiation, and 
chronic inflammatory 
diseases.
No established etiology 
Macroscopy Multiple or single 
small nodular lesions 
incidentally detected 
during surgery (0.5 to 
3 cm)
Multiple confluent 
translucent cysts form-
ing a mass, without 
hemorrhage, fat or 
calcifications in their 
walls 
Encapsulated and solid 
lesions
Solitary bulky lesion, 
usually small (2cm or 
less); with no capsule; 
may present small 
cystic components
Clinical signs and 
symptoms
Asymptomatic tumor 
(55%)
Abdominal pain 
(38.3%)
Ascites (33.3%)
Pelvic mass (11.1%)
Chronic pelvic inflam-
matory disease (11.1%)
Constipation (5.5%)
Abdominal mass (29%) 
+ distension/abdominal 
pain (46%)
Asymptomatic abdomi-
nal mass (18%)
Abdominal pain syn-
drome
Ascites
Abdominal mass 
Alterations of intestinal 
transit (alternating diar-
rhea and constipation 
or symptoms simulat-
ing an obstructive 
crisis).
Asymptomatic (inciden-
tal finding)
Abdominal pain 
Weight loss
Loss of appetite
Nausea
Ascites
Pelvic mass
Survival More than five years 
after diagnosis
Mean survival of 8-12 
months after diagno-
sis (10) 
Treatment Surgical The tumor is not sensi-
tive to chemotherapy or 
radiotherapy
Surgical Cytoreduction surgery 
with extensive perito-
nectomy and periop-
erative intraperitoneal 
chemotherapy
Surgical
Location 26% in abdominal or 
pelvic organs
22% in the omentum
16% on the pelvic wall
14% in the mesentery
14% in the peritoneum
8% in the Douglas 
cul-de-sac
Genital tract of both 
sexes 
Number of reported 
cases 
41 cases 130 cases 15 cases  1-2 cases/million 
inhabitants/year
Prognosis Possibility of malignant 
transformation
Local recurrence  Local recurrence Local recurrence Local recurrence
Differential diagnosis Serous tumor of the 
ovarian surface
Metastatic tumor usu-
ally of the gastrointesti-
nal tract
Cystic lymphangioma
Endometriosis
Cystoadenoma and 
cystoadenocarcinoma 
of the ovary
Teratoma
Peritoneal pseudomi-
xoma 
Necrotic leiomyoma - 
Leiomyosarcoma
Peritoneal inclusion 
cyst 
Peritoneal tuberculosis
Peritoneal carcinoma-
tosis Peritoneal
lymphoma
Metastases of an ovar-
ian carcinoma 
Malignant mesothe-
lioma 
Mesothelial hyperplasia 
Well-differentiated 
papilliferous peritoneal 
mesothelioma 
Metastases 268
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Table 3 - Positivity of immunohistochemical markers in 
adenocarcinomas and mesotheliomas11, 25
Adenocarcinomas 
(%)
Mesotheliomas 
(%)
CEA 90-100 0-10
B72.3 81 0-5
BEREP4 90-100 0-11
CD15(LEU-M1) 58-100 0-10
Calretinin 6-9 42-100
in the cul-de-sac and its histopathological characteristics 
(cells clustered in a papillary formation), it was necessary 
to establish a differential diagnosis with adenocarcinoma.1 
Histology revealed medium-sized polygonal cells in an 
acinar, tubular and papilliform cell arrangement, a low 
mitotic index (up to 1), a mild grade of atypia, abundant 
vascularization, and absence of necrosis, suggesting an 
adenomatoid tumor.14
Immunohistochemistry revealed positivity for calretinin, 
which labels mesothelial cells in 60 to 100% of cases1,9,13 
and rarely labels adenocarcinomas (0 to 28%). In addition, 
the cells of the neoplasia reported here were negative for 
BerEp4, which labels epithelial cells that are not present in 
mesotheliomas.2,5 The present case was negative for CEA 
immunoreagent, which frequently labels pulmonary and 
gastrointestinal carcinomas and is detected in only 0 to 35% 
of serous ovarian carcinomas.2,16 Thus, negativity of this 
marker is of no help for differentiation between adenomatoid 
tumors and adenocarcinomas. The possibility of the latter 
was ruled out due to immunohistochemistry compatible 
with an adenomatoid tumor, and by MRI and laparotomy 
findings that revealed disease-free ovaries. Another possible 
differential diagnosis for this case, arising from its location 
in a cul-de-sac, would be a metastatic tumor. However, 
CEA negativity and calretinin positivity do not favor this 
possibility, as demonstrated in Table 3. Other differential 
diagnoses are cysts of peritoneal inclusion, hemangiomas, 
lymphangiomas,12 mesothelial hyperplasia, malignant 
mesotheliomas,9 and well-differentiated papilliferous 
mesotheliomas.
Mesothelial hyperplasia has been associated with 
peritoneal insults such as hernia, ectopic tubal pregnancy, and 
abdominal cirrhosis and tuberculosis3 and is accompanied 
by adherences and chronic inflammation.14 This entity 
rarely produces tumoral masses and does not have the 
tubulopapilliferous complex or the labyrinth architecture 
of mesotheliomas.14 The differential diagnosis with 
malignant mesothelioma and well-differentiated papilliferous 
mesothelioma is made on the basis of the distinct histological 
characteristics of these tumors when compared to AMP.17
MR has become a valuable noninvasive technique for 
evaluation of the female pelvis,18-20 with advantages over 
computed tomography and ultrasound for diagnosis and 
for staging various pathological conditions of the pelvis 
(leiomyoma, adenomyosis, carcinoma of the endometrium 
and of the uterine cervix, carcinoma of the vagina, ovarian 
cysts, endometriosis, teratomas, polycystic ovaries, and other 
ovarian masses).18,20
MR has proven to be a highly sensitive modality for 
characterization of pelvic masses, allowing physicians to 
determine whether the pelvic mass is uterine or of adnexal 
origin and also to characterize most adnexal masses.20 
MR can also provide multiplanar information, revealing 
additional information when compared to CT or US. This 
is especially true along the pelvic walls and the presacral 
space.18,20 MR is also especially useful for surgical planning15 
and patient follow-up. Low et al21 studied 24 patients with 
suspected peritoneal tumors and found that MR had higher 
sensitivity, specificity and accuracy than CT in the detection 
of tumors (84%, 87% and 86%, compared to 54%, 91% and 
74%, respectively, for CT) and was superior for detection 
of carcinomatosis and of tumors measuring less than 1 cm 
in diameter (75% to 80% for MR and 22% to 33% for CT). 
Post-contrast T1-weighted images with fat suppression 
were proven to be the most sensitive MR technique for 
detecting peritoneal disease. MR and CT showed identical 
performance for detection of tumors measuring more than 2 
cm and 1 to 2 cm in diameter.21
Notably, the high sensitivity of the MR exam could 
depict both ovaries as free of disease and was able to 
characterize the lesion as not having ovarian or uterine 
origin; this could not be achieved by ultrasound examination. 
Also, to date, we believe that this is the first case both to 
show MR findings for AMP and to correlate these findings 
to ultrasound and computed tomography. Descriptions of 
imaging findings regarding AMP are scarce in the literature. 
AMP seems to have no specific radiological characteristics, 
and it is important to establish a correlation between 
clinical presentation and the imaging and laboratory 
findings. At this point, it is necessary to reinforce that 
diagnosis can only be confirmed by anatomopathology and 
immunohistochemistry. 269
CLINICS 2009;64(3):264-9 MRI of peritoneal adenomatoid mesothelioma
Lins CMC et al.
REFERENCES
1.  Hanada S, Okumura Y, Kaida K. Multicentric adenomatoid tumors 
involving uterus, ovary, and appendix. J Obstet Gynaecol Res. 
2003;29:234-8.
2.  Hoekman K, Tognon G, Risse EK, Bloemsma CA, Vermorken JB. 
Well-differentiated papillary mesothelioma of the peritoneum: a separate 
entity. Eur J Cancer. 1996; 32A:255-8.
3.  Hayes SJ, Clark P, Mathias R, Formela L, Vickers J, Armstrong GR. 
Multiple adenomatoid tumours in the liver and peritoneum. J Clin Pathol. 
2007;60:722-4.
4.  Wong WL, Johns TA, Herlihy WG, Martin HL. Best cases from the 
AFIP: multicystic mesothelioma. Radiographics. 2004;24:247-50.
5.  Davidson B. Biological characteristics of cancers involving the serosal 
cavities. Crit Rev Oncog. 2007;13:189-227.
6.  Adachi T, Sugiyama Y, Saji S. Solitary fibrous benign mesothelioma of 
the peritoneum: report of a case. Surg Today. 1999;29:915-8.
7.  Sawh RN, Malpica A, Deavers MT, Liu J, Silva EG. Benign cystic 
mesothelioma of the peritoneum: a clinicopathologic study of 17 
cases and immunohistochemical analysis of estrogen and progesterone 
receptor status. Hum Pathol. 2003;34:369-74.
8.  Daya D, McCaughey W.T. Pathology of the peritoneum: a review of 
selected topics. Semin Diagn Pathol. 1991;8:277-89.
9.  Isotalo PA, Nascimento AG, Trastek VF, Wold LE, Cheville JC. 
Extragenital adenomatoid tumor of a mediastinal lymph node. Mayo 
Clin Proc. 2003;78:350-4.
10.  Gokce G, Kilicarslan H, Ayan S, Yildiz E, Kaya K, Gultekin EY. 
Adenomatoid tumors of testis and epididymis: a report of two cases. 
Int Urol Nephrol. 2001;32:677-80.
11.  Cajaiba MM, Senise SM, Osório CABdT, Pinto CAL. Adenomatoid 
Tumor of Myometrium: Report of Three Cases. Applied Cancer 
Research. 2005;25:3.
12.  Ghossain MA, Chucrallah A, Kanso H, Aoun NJ, Abboud J. Multilocular 
adenomatoid tumor of the ovary: ultrasonographic findings. J Clin 
Ultrasound. 2005;33:233-6.
13.  Hamamatsu A, Arai T, Iwamoto M, Kato T, Sawabe M. Adenomatoid 
tumor of the adrenal gland: case report with immunohistochemical study. 
Pathol Int. 2005;55:665-9.
14.  Goldblum J., Hart W.R. Localized and diffuse mesotheliomas of the 
genital tract and peritoneum in women. A clinicopathologic study of 
nineteen true mesothelial neoplasms, other than adenomatoid tumors, 
multicystic mesotheliomas, and localized fibrous tumors. Am J Surg 
Pathol. 1995;19:1124-37.
15.  Devine C, Szklaruk J, Tamm EP. Magnetic resonance imaging in 
the characterization of pelvic masses. Semin Ultrasound CT MR. 
2005;26:172-204.
16.  Trupiano JK, Geisinger KR, Willingham MC, Manders P, Zbieranski 
N, Case D; et al. Diffuse malignant mesothelioma of the peritoneum 
and pleura, analysis of markers. Mod Pathol. 2004;17:476-81.
17.  Bhandarkar DS, Smith VJ, Evans DA, Taylor TV. Benign cystic 
peritoneal mesothelioma. J Clin Pathol. 1993;46:867-8.
18.  van Ruth S., Bronkhorst MW, van Coevorden F, Zoetmulder FA. 
Peritoneal benign cystic mesothelioma: a case report and review of the 
literature. Eur J Surg Oncol. 2002;28: 192-5.
19.  Szklaruk J, Tamm EP, Choi H, Varavithya V. MR imaging of common 
and uncommon large pelvic masses. Radiographics. 2003;23:403-24.
20.  Olson MC, Posniak HV, Tempany CM, Dudiak CM. MR imaging of 
the female pelvic region. Radiographics. 1992;12:445-65.
21.  Low RN, Barone RM, Lacey C, Sigeti JS, Alzate GD, Sebrechts C.P. 
Peritoneal tumor: MR imaging with dilute oral barium and intravenous 
gadolinium-containing contrast agents compared with unenhanced MR 
imaging and CT. Radiology 1997;204:513-20.
22.  Bui-Mansfield LT, Kim-Ahn G, O’Bryant LK. Multicystic mesothelioma 
of the peritoneum. AJR Am J Roentgenol. 2002;178:402.
23.  Ozgen A, Akata D, Akhan O, Tez M, Gedikoglu G, Ozmen MN. Giant 
benign cystic peritoneal mesothelioma: US, CT, and MRI findings. 
Abdom Imaging. 1998;23:502-4.
24.  Romero JA, Kim EE, Kudelka AP, Edwards CL, Kavanagh JJ. MRI of 
recurrent cystic mesothelioma: differential diagnosis of cystic pelvic 
masses. Gynecol Oncol. 1994;54:377-80.
25.  Soreide JA, Soreide K, Korner H, Soiland H, Greve OJ, Gudlaugsson E. 
Benign peritoneal cystic mesothelioma. World J Surg. 2006;30:560-6.
26.  Puvaneswary M, Chen S, Proietto T. Peritoneal mesothelioma: CT and 
MRI findings. Australas Radiol. 2002;46:91-6.